This inventor holds 1 USPTO granted patent. Top assignee: Syngenta Participations Ag. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Michele Yarnell: Innovator in Synthetic Protein Scaffolds
Introduction
Michele Yarnell is a prominent inventor based in Research Triangle Park, NC (US). She has made significant contributions to the field of biotechnology, particularly in the development of synthetic non-antibody protein scaffolds. Her innovative work has the potential to enhance the detection of target proteins in complex biological matrices.
Latest Patents
Michele Yarnell holds a patent for her invention titled "Non-antibody ligands for detecting target proteins." This invention relates to synthetic non-antibody protein scaffolds (synNAPS) that can differentially detect or quantify a target insecticidal protein amidst a complex biological matrix. The patent focuses on methods of using synNAPS in immunoassays, specifically for the differential detection and quantification of wild-type crystal proteins, such as wild-type-Cry1Ab, from hybrid crystal proteins.
Career Highlights
Michele Yarnell has established herself as a key figure in her field, working with Syngenta Participations AG. Her expertise in synthetic protein scaffolds has positioned her as a valuable asset in the biotechnology sector. With a total of 1 patent, her contributions are recognized for their potential impact on agricultural biotechnology.
Collaborations
Michele collaborates with talented individuals such as Anne Chevrel and Olivier Kitten. These partnerships enhance her research and development efforts, fostering innovation in the field.
Conclusion
Michele Yarnell's work in synthetic non-antibody protein scaffolds represents a significant advancement in the detection of target proteins. Her innovative approach and collaboration with industry experts continue to drive progress in biotechnology.